However, SOCS2 is highly upregulated and has tumor-promoting functions in the advanced stages of chronic myeloid leukemia and in high-grade anal intraepithelial lesions12,13. The gene discussed is SOCS2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.